Oncological Complications

A Brief Overview of Oncological Complications

Radiotherapy is a cornerstone of modern oncology and has contributed to saving the lives of millions of patients worldwide. However, tissues within the radiation field undergo biological changes that are not limited to the active phase of treatment; on the contrary, they often manifest months or even years later, creating painful and disproportionately serious complications.

Radiation-induced injuries result from the gradual fibrotic degeneration and vascular damage caused by radiation to irradiated tissues. The result is chronic hypoxia, impaired regenerative capacity, and increased susceptibility to infection and necrosis.

Hyperbaric oxygen chamber therapy addresses precisely this underlying pathology: it restores oxygenation to irradiated tissues, reactivates regenerative mechanisms that have become impaired, and significantly improves the patient’s quality of life, always as a complementary intervention within the framework of oncological care.

Oncological Complications & Treatment

In oncological complications, hyperbaric oxygen chamber therapy differs in its objective from other applications: here, it does not treat an acute injury but rather chronic, established pathology caused by cancer treatment.

Hypoxia in irradiated tissues is not temporary; it is structural, resulting from the permanent vascular damage caused by radiation. Without intervention, it may worsen over time.

Repeated exposure to high concentrations of oxygen helps “break” this vicious cycle: it restores oxygenation in chronically hypoxic tissues, stimulates neoangiogenesis to create new blood vessels in place of damaged ones, reduces chronic inflammation, and reactivates cells that have become biologically inactive.

The result is improved function of irradiated tissues and a reduction in symptoms that negatively affect quality of life.

Scientific Studies

Radiation-induced complications are among the most extensively documented indications for hyperbaric oxygen in the international scientific literature. The UHMS and ECHM classify conditions such as osteoradionecrosis, radiation-induced cystitis, radiation-induced proctitis/colitis, and soft-tissue radiation injuries as approved indications, with a high level of clinical evidence.

Randomized clinical studies have demonstrated significant improvements in healing parameters, reductions in pain, and improvements in quality of life among patients who received hyperbaric oxygen for radiation-induced complications.

The scientific evidence consistently emphasizes the importance of early intervention, before tissue damage progresses to irreversible necrosis, as well as individualized treatment under oncological supervision.